Robert-



This has the smell of a Nazi project. Any fascists in this deCode Genetics
company?

Who's your best Nazi researcher? You might want to have him/her take a look at
this.

XXX XXX

http://www.washingtonpost.com/wp-srv/WPcap/1999-01/12/061r-011299-idx.html



Iceland to Make Its Genetic Code a Commodity

Plan to Study Disease Highlights Conflict Between Scientific Advances, Privacy
Fears

By John Schwartz

Washington Post Staff Writer

Tuesday, January 12, 1999; Page A01



Iceland has decided to become the first country in the world to sell the
rights to the entire population's genetic code to a biotechnology company -- a
move that is highlighting the promise and risks of the genetic information
age.



The strikingly uniform DNA of Iceland's largely blue-eyed, blond-haired
populace is expected to provide an invaluable resource for studying human
genetics, leading to fundamental insights into many diseases, proponents say.



"It really is a complete paradigm shift in medicine," said Jonathan Knowles,
who heads research at Roche Holding Ltd., which has signed a $200 million,
five-year deal to develop new drugs and tests from the data.



But the plan is highly controversial because it will pool richly detailed
genetic, medical and genealogical information about Iceland's 270,000
residents into a set of linked databases that companies will search for clues
into the nature of disease. Although a majority of Iceland's citizens support
the plan, a vocal minority of scientists and doctors -- with support from a
worldwide network of like-minded privacy advocates -- have stoked the
controversy.



"Most doctors and scientists here in Iceland are in favor of the basic purpose
of this project -- but find the proposed solution quite unethical and
unrealistic," said Jon Erlendsson, a Reykjavik-based engineer and writer who
believes the database network will eventually fail because doctors and
patients will refuse to cooperate once its nature is better understood.



Opponents fear the database could make the most private details of
individuals' lives public. People with mental illness or other health problems
could be stigmatized, perhaps suffering job discrimination. Patients may
become less willing to divulge personal information to their doctors. And in a
country where some estimates say that about 10 percent of the population may
have been born out of wedlock, long-held family secrets could leak out.



The fight in Iceland is focusing attention on the potential risks of efforts
to mine and refine personal data -- efforts that are also increasingly common
in the United States and around the world.



"Turning the population into electronic guinea pigs" should serve as a warning
to Americans, said David Banisar of the Washington-based Electronic Privacy
Information Center.



Despite the objections, Iceland could begin collecting blood to obtain the DNA
samples within six months, after a period in which citizens may decline to
participate. Precisely how the blood will be collected has not been
determined.



The plan was proposed by Kari Stefansson, a Harvard-educated Icelandic
scientist, in part as a way to develop a new natural resource for a country
where unemployment is a chronic problem. Iceland's parliament, the Althing,
approved the plan last month, passing a law authorizing the database and
creating the framework that will enable a local company, deCODE Genetics, to
hold an unusual 12-year monopoly on data marketing rights.



Iceland's population presents a tantalizing opportunity for those who study
genetics because all of that blond hair and blue eyes reflects one of the most
remarkably homogeneous populations in the world. The original blend of 9th
century Norse stock and Celtic seamen has been largely unchanged, and that
gene pool was further restricted by bouts of plague, famine and volcanic
eruption.



This comparatively simple set of genes makes genetic prospecting far less
daunting than attempting to track down faulty genes among the millions of
chemical components arrayed along the human chromosomes in heterogeneous
populations like that of the United States.



(It's a little like trying to detect a single flat note sung by one person
while wandering through a public park in which everyone is singing his own
favorite tune: The distractions of the merengue, the klezmer, the classical
and the sea chanteys make it even harder to find the errant note. A
homogeneous population such as Iceland's, however, is more like a chorus, with
most people singing from the same page -- so it's much easier to discern when
one of the singers is off.)



Because Iceland has a strong health care system with extensive record-keeping,
as well as genealogical records that go back hundreds of years, it offers
tremendous potential for ferreting out the relationship between the genetic
and environmental origins of disease, said Stefansson. Researchers will be
able to sift through the data to uncover medical insights "in a systematic
manner," Stefansson said, adding that "it's going to be a great discovery
tool."



Those in Iceland supporting the plan say it strikes a careful balance between
the rights of the citizenry and the needs of science. The unified health
database will "improve delivery of health services. . . . On balance, I think
the potential advantages will outweigh the risks involved," said Solveig
Petursdottir, a member of parliament who voted for it.



Opponents of the law cite numerous problems. Many of them are among the
nation's leading scientists and scholars. They argue their case in Icelandic
and English on their Web site, and have formed an advocacy group, Mannvernd,
"to promote ethical standards in medical research, science and in the
biotechnology industry in Iceland" and to oppose the new law, which the
group's Web site says "infringes upon accepted medical, scientific and
commercial standards." They say that they understand the importance of
deCode's work and support earlier efforts by the company to understand genetic
diseases by studying the DNA of Icelandic volunteers. But the new plan, they
say, takes away too much privacy -- for private gain -- and gives too little
back to the nation and to science.



"When you put genealogical information into the databank and also genetic
data, then the databank knows more about you than you know about yourself,"
said Tomas Zoega, chairman of the Icelandic Medical Association's ethics
council. "Some look at it as a fantastic idea. But I think the idea is a scary
one."



Opponents complain that they still have not been told how the DNA will be
collected, or how much information will be stored in the database. Those
details will be decided by a government-created committee.



The company has promised to collect the data "anonymously" but uses that word
with great nuance, opponents say. Among most database experts, "anonymous"
almost always means that identifying information will be stripped away. But in
this case, the information directly identifying individuals will be encrypted
so that it cannot easily be read by unauthorized people.



British researcher Ross Anderson has prepared a paper for the Icelandic
Medical Association that questions the notion that anonymity can be protected
when so much data is collected. The company has pledged to program the
computers to produce no fewer than 10 records for any query so that the
computers can never identify an individual. But multiple searches can winnow
one name out of 10, Anderson said, adding that no encryption scheme can mask
identities when so much personal information is stored in one place.



Opponents also argue that the pay-as-you-go research concept damages the
spirit of science, in which knowledge should be freely shared.



Most important from a doctor's point of view, Zoega said, is the possibility
that "trust between patients and physicians will diminish and maybe disappear"
if people believe that every fact about them will be entered into the
database.



As for those who support it, "I think that those are the people who have not
been ill, who do not have medical records lying about," said Petur Hauksson, a
psychiatrist who chairs the Icelandic Psychiatric Patients Association.



Opposition to the database law is, if anything, even stronger outside of
Iceland. Privacy officials of the European Union have been sharply critical of
the database proposal. Researchers with expertise in genetics and public
policy said that the nation's scientific goal is laudable but that the plan is
flawed.



Simon Davies, head of the London-based Privacy International, said the trend
toward the collection of more data at the expense of privacy is a worldwide
problem. "A sensible civil libertarian will say the democratic process failed
us. It's all just evaporated in the past five years."



Davies said people are too quick to accede to arguments based on "economic
rationalism" without thinking about the broader implications. "Thin-lipped
accountants have taken control," he said.



Iceland has gone further than other European nations, Davies said, but it will
not be alone for long. "What we're seeing in Iceland is just the forerunner of
a Europe-wide mechanism," Davies said. "Wherever you see a bad law, you can
bet that the rest of Europe will sink to that level and integrate."



Pharmaceutical scientist Knowles acknowledged the potential for abuse. "We
must do everything possible to ensure that privacy of individuals is
maintained," he said. Because the data will be used to look for statistical
relationships in large populations, the company has no motivation to examine
information about specific persons, he said. "Individual data is of no use
whatsoever."



Fears of abuse should be addressed through legislation, not by restricting the
project, Stefansson said. "We should not let the bad guys dictate" public
policy, he said. "We're not going to let people die simply because it might be
abused.



"You do not place limitations on the creation of new knowledge," he said, "you
place limitations on the ways that the new knowledge can be used."





� Copyright 1999 The Washington Post Company



Reply via email to